Synexus, the world’s largest company responsible for the recruitment and running of clinical trials, has won its first contract to conduct ophthalmology studies.
Category: News
UK Recognition For Top Queen’s Scientist For Research Into Vascular Stem Cells And Eye Disease
One of Northern Ireland’s leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen’s University…
AMD Geographic Atrophy Clue Raises Therapy Hope For Major Cause Of Blindness
Discovery of a key enzyme mechanism in geographic atrophy, a late stage in “dry type” age-related macular degeneration (AMD), is raising hope of two possible new therapies for a major cause of untreatable blindness in the industrialized world…
Researchers discover molecular mechanism implicated in geographic atrophy
A team of researchers, led by University of Kentucky ophthalmologist Dr. Jayakrishna Ambati, has discovered a molecular mechanism implicated in geographic atrophy, the major cause of untreatable blindness in the industrialized world.
Postop Monitoring, Updated Techniques Improve Cataract Surgery Outcomes
Routine monitoring and updated techniques in cataract surgery improved visual outcomes over time, a large Indian study showed.
Alimera Announces Positive 36-Month Results From The Completed Phase 3 FAMET Study Of ILUVIEN® In Patients With Diabetic Macular Edema
28.4% and 29.0% demonstrated improvement in best corrected visual acuity (BCVA) of 15 letters from baseline, at three years. Statistical significance seen in both trials as late as month 33.
Postop Monitoring, Updated Techniques Improve Cataract Surgery Outcomes
Routine monitoring and updated techniques in cataract surgery improved visual outcomes over time, a large Indian study showed.
UM Researchers Identify New Gene Causing Blindness
Researchers led by geneticists at the University of Miami Miller School of Medicine have identified a new gene that causes retinitis pigmentosa, a form of blindness, ending one South Florida family’s nearly 20-year search for what caused three of their…
Greater Insight Into LASIK Quality Of Life Collaboration Project
The American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery today issued the following statement on the LASIK Quality of Life Collaboration Project. During a recent LASIK panel symposium and subsequent discussions …
CVVS scientist receives top UK award for ground-breaking research on vascular stem cells, eye disease
One of Northern Ireland’s leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen’s University.
Dual-Focus Soft Contact Lenses Slow Myopia Progression in Childhood
Results of an early phase trial indicate that an experimental dual-focus soft contact lens can reduce myopia progression in children, according to a New Zealand team. Reuters Health Information
Queen’s scientist awarded Royal Society Wolfson Research Merit Award
One of Northern Ireland’s leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen’s University.
Fera Pharmaceuticals Launches OTC Puralube(R) Ophthalmic Ointment For Dry Eye
Puralube® Ophthalmic Ointment, is now available from Fera Pharmaceuticals. Puralube, a preservative free ophthalmic ointment, is one that has been relied upon by patients and healthcare professionals for years to relieve the symptoms of dry eye. When…
ACUMINDER™ Tool Helping To Change Contact Lens Wearing Behavior, Survey Shows
Even though eye care doctors and manufacturers provide instructions about caring for and wearing contact lenses, studies show that many contact lens wearers do not comply with the recommended replacement frequencies and fail to discard their lenses aft…
UM researchers find genetic cause of retinitis pigmentosa
Researchers led by geneticists at the University of Miami Miller School of Medicine have identified a new gene that causes retinitis pigmentosa, a form of blindness, ending one South Florida family’s nearly 20-year search for what caused three of their…
Alimera reports 36-month results from ILUVIEN Phase 3 FAME study for DME
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today reported results through month 36 of the completed FAME™ Study.
Positive top-line results from ILUVIEN Phase 3 trial in patients with DME
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, including the investigational drug ILUVIEN for the treatment of Diabetic Macular Edema, today announced month 36, top-line readou…
Rapid Treatment Of Acute Primary Angle Closure May Ward Off Increased Cup-To-Disc Ratio
If treated promptly, a single episode of acute primary angle closure may not necessarily increase cup-to-disc ratio, but retinal nerve fiber layer loss may occur, a study found.
Rapid Treatment Of Acute Primary Angle Closure May Ward Off Increased Cup-To-Disc Ratio
If treated promptly, a single episode of acute primary angle closure may not necessarily increase cup-to-disc ratio, but retinal nerve fiber layer loss may occur, a study found.
Triamcinolone Aids Laser Treatment of Diabetic Macular Edema
Pretreatment with intravitreal triamcinolone acetonide (IVTA) improves laser therapy of diabetic macular edema, Australian researchers reported online January 12th in Ophthalmology. Reuters Health Information